{
  "study_id": "study_16",
  "study_info": {
    "title": "A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion",
    "journal": "Case Reports in Endocrinology",
    "year": 2020,
    "volume_issue": "2020:4147097",
    "doi": "10.1155/2020/4147097",
    "country": "Italy",
    "study_type": "Case report",
    "authors": [
      "Carlotta Giani",
      "Teresa Ramone",
      "Cristina Romei",
      "Raffaele Ciampi",
      "Alessia Tacito",
      "Laura Valerio",
      "Laura Agate",
      "Clara Ugolini",
      "Michele Marinò",
      "Fulvio Basolo",
      "Alessandro Franchi",
      "Simona Borsari",
      "Angela Michelucci",
      "Gabriele Materazzi",
      "Cesare Selli",
      "Rossella Elisei"
    ],
    "keywords": [
      "MEN2",
      "MEN2A",
      "MEN2B",
      "RET",
      "medullary thyroid carcinoma",
      "primary hyperparathyroidism",
      "plexiform neurofibroma",
      "ganglioneuromatosis",
      "megacolon",
      "marfanoid habitus"
    ]
  },
  "cohort_info": {
    "total_patients": 1,
    "sex_distribution": {
      "male": 0,
      "female": 1
    },
    "age_stats": {
      "mean": 7,
      "median": 7,
      "range": "7-7"
    },
    "sporadic_definition_criteria": "Case described as carrying a de novo RET germline deletion not detected in the blood of the parents or brother, indicating absence of familial transmission.",
    "tumor_staging_distribution": {
      "stage_I": 0,
      "stage_II": 0,
      "stage_III": 0,
      "stage_IV": 0
    },
    "followup_groups": {
      "disease_free": null,
      "biochemical_persistent": null,
      "structural_disease": null
    }
  },
  "mutation_summary": {
    "ret_mutated_cases": 1,
    "ras_mutated_cases": 0,
    "mutation_negative_cases": 0,
    "mutations": [
      {
        "gene": "RET",
        "variant": "Exon11_Asp631_Leu633delinsGlu",
        "count": 1
      }
    ]
  },
  "case_data": [
    {
      "case_id": 1,
      "mutation": "RET Exon11_Asp631_Leu633delinsGlu",
      "tissue_vaf": null,
      "preop_ctdna_vaf": null,
      "postop_ctdna_vaf": null,
      "preop_ct": 496,
      "preop_cea": null,
      "postop_ct": 52,
      "postop_cea": null,
      "postop_timing_months": 2,
      "tki": "No",
      "outcome": "Biochemical",
      "ctdna_positive_preop": null,
      "ctdna_positive_postop": null
    }
  ],
  "patients": [
    {
      "id": "proband",
      "age": 7,
      "sex": "Female",
      "relationship": "Proband",
      "ret_variant": "Exon11_Asp631_Leu633delinsGlu",
      "biochemical_data": [
        {
          "analyte": "calcitonin",
          "value": 665,
          "unit": "pg/ml",
          "context": "Pre-referral local measurement described as 665 pg/ml Ct with thyroid nodules.",
          "timing": "pre-diagnosis",
          "reference_range": null,
          "elevated": true
        },
        {
          "analyte": "calcitonin",
          "value": 496,
          "unit": "ng/L",
          "context": "Baseline at referral to endocrine unit before thyroid surgery.",
          "timing": "preoperative",
          "reference_range": "<18 ng/L",
          "elevated": true
        },
        {
          "analyte": "calcitonin",
          "value": 52,
          "unit": "ng/L",
          "context": "Follow-up two months after surgery.",
          "timing": "2_months_postoperative",
          "reference_range": "8-18 ng/L (upper limit 18 ng/L for Ct reported separately from PTH range)",
          "elevated": true
        },
        {
          "analyte": "calcium",
          "value": 11.3,
          "unit": "mg/dl",
          "context": "Initial detection at 7 years of age triggering evaluation for hyperparathyroidism.",
          "timing": "preoperative",
          "reference_range": null,
          "elevated": true
        },
        {
          "analyte": "PTH",
          "value": 49,
          "unit": "pg/ml",
          "context": "Initial PTH when calcium 11.3 mg/dl at 7 years.",
          "timing": "preoperative",
          "reference_range": null,
          "elevated": true
        },
        {
          "analyte": "calcium",
          "value": 11.2,
          "unit": "mg/dL",
          "context": "Hypercalcemia at presentation to endocrine unit with MTC.",
          "timing": "preoperative",
          "reference_range": "8.6-10.2 mg/dL",
          "elevated": true
        },
        {
          "analyte": "PTH",
          "value": 51,
          "unit": "ng/L",
          "context": "PTH at same time as calcium 11.2 mg/dL and Ct 496 ng/L.",
          "timing": "preoperative",
          "reference_range": "8-40 ng/L",
          "elevated": true
        },
        {
          "analyte": "bone_specific_alkaline_phosphatase",
          "value": 127,
          "unit": "μg/L",
          "context": "Preoperative B-ALP associated with hyperparathyroidism.",
          "timing": "preoperative",
          "reference_range": "4.7-27.1 μg/L",
          "elevated": true
        },
        {
          "analyte": "osteocalcin",
          "value": 98.7,
          "unit": "μg/L",
          "context": "Preoperative osteocalcin associated with hyperparathyroidism.",
          "timing": "preoperative",
          "reference_range": "10.4-45.6 μg/L",
          "elevated": true
        },
        {
          "analyte": "25_hydroxy_vitamin_D",
          "value": 21,
          "unit": "μg/L",
          "context": "Preoperative vitamin D status.",
          "timing": "preoperative",
          "reference_range": ">30 μg/L",
          "elevated": false
        },
        {
          "analyte": "calcium",
          "value": 9.5,
          "unit": "mg/dl",
          "context": "Calcium on calcitriol therapy two months after surgery.",
          "timing": "2_months_postoperative",
          "reference_range": "8.6-10.2 mg/dl",
          "elevated": false
        },
        {
          "analyte": "PTH",
          "value": 21,
          "unit": "ng/L",
          "context": "PTH two months after surgery while on calcitriol.",
          "timing": "2_months_postoperative",
          "reference_range": "8-40 ng/L",
          "elevated": false
        },
        {
          "analyte": "bone_specific_alkaline_phosphatase",
          "value": 75,
          "unit": "μg/L",
          "context": "B-ALP two months after surgery.",
          "timing": "2_months_postoperative",
          "reference_range": "4.7-27.1 μg/L",
          "elevated": true
        },
        {
          "analyte": "osteocalcin",
          "value": 79.4,
          "unit": "μg/L",
          "context": "Osteocalcin two months after surgery.",
          "timing": "2_months_postoperative",
          "reference_range": "10.4-45.6 μg/L",
          "elevated": true
        }
      ],
      "diagnoses": [
        "medullary thyroid carcinoma",
        "MEN2B-like phenotype",
        "primary hyperparathyroidism",
        "C-cell hyperplasia",
        "plexiform neurofibroma of bladder/pelvis",
        "diffuse ganglioneuromatosis (intestinal and bladder)",
        "megacolon",
        "vesicoureteral reflux with recurrent pyelonephritis",
        "marfanoid habitus",
        "mucosal neuromas"
      ],
      "imaging": [
        "Neck ultrasound at 7 years: bilateral solid hypoechoic thyroid micronodules; left roundish hypoechoic extrathyroid lesion of 9 mm suspected lymphadenopathy or hyperplastic parathyroid; latero-cervical lymphadenopathies.",
        "Neck ultrasound preoperatively: three bilateral micronodules, suspicious left solid hypoechoic thyroid nodule 11 mm with irregular margin; 9 mm hypoechoic nodular lesion below left lobe suspected hyperplastic parathyroid; multiple jugular and left latero-cervical microlymphadenopathies.",
        "Total body CT scan: excluded distant metastases; showed megacolon.",
        "Pelvic MRI at age 2 and follow-up: large pelvic solid expansive lesion 14 cm extending to pubic region around urethra and bladder causing mild hydronephrosis; described as stable over time, consistent with plexiform neurofibroma.",
        "Gastrointestinal scintigraphy at age 2: slowed gastric emptying.",
        "Gastroscopy: irregular small duodenum with esophagitis.",
        "Adrenal imaging: negative for pheochromocytoma.",
        "Abdominal CT and MRI eight months after surgery: no metastatic lesions, stability of pelvic mass."
      ],
      "pathology": [
        "Thyroid: multifocal bilateral medullary thyroid carcinoma; four microfoci (three left lobe, one right lobe); largest focus approximately 1 cm in left lobe; associated C-cell hyperplasia.",
        "Tumor invasion: largest microfocus invaded perithyroid soft tissue with extensive neoplastic lymphangiosis and vascular embolization; neoplastic vascular emboli and deposits infiltrating adjacent ganglioneuromatosis lesion.",
        "Lymph nodes: central compartment 5/10 positive, left latero-cervical 5/32 positive for MTC metastases.",
        "Pathologic stage: pT1a(m)N1bM0 (AJCC 8th edition).",
        "Parathyroid: one hyperplastic parathyroid (6 mm) and one parathyroid adenoma (8 mm).",
        "Mucosal neuromas: histology consistent with diffuse ganglioneuromatosis of oral mucosa.",
        "Pelvic lesion: plexiform neurofibroma with diffuse ganglioneuromatosis involving bladder wall; S100-positive spindle cells; ganglion-like cells positive for synaptophysin and neuron specific enolase; EMA-positive perineurial cells around fascicles."
      ],
      "genetics": {
        "ret_variant_coding": "c.1893_1898delCGAGCT",
        "ret_variant_protein": "Asp631_Leu633delinsGlu",
        "ret_m918t": "absent",
        "zygocity": "heterozygous",
        "inheritance": "de_novo",
        "pathogenicity_classification": "pathogenic",
        "somatic_mutations_in_MTC": [],
        "other_genes_tested": ["MEN1", "CDKN1B", "NF1", "PTEN", "FBN1", "SOS1"],
        "other_genes_variants_found": []
      },
      "family_history": {
        "mtc": false,
        "pheochromocytoma": false,
        "hyperparathyroidism": false,
        "other_men_related_tumors": false,
        "notes": "Parents and brother tested negative for the RET germline deletion; no familial MEN2 features reported."
      },
      "surgery": [
        "Total thyroidectomy.",
        "Central compartment lymph node dissection.",
        "Left latero-cervical lymph node dissection.",
        "Bilateral neck exploration for primary hyperparathyroidism with removal of hyperplastic parathyroid and parathyroid adenoma.",
        "Biopsy of mucosal neuromas of the mouth.",
        "Prior laparotomy at age 2 for debulking of unresectable pelvic mass (plexiform neurofibroma)."
      ],
      "follow_up": [
        "Two months post-thyroidectomy: serum calcitonin 52 ng/L, calcium 9.5 mg/dl on calcitriol 0.25 μg/day, PTH 21 ng/L, B-ALP 75 μg/L, osteocalcin 79.4 μg/L; neck ultrasound showed no local recurrence.",
        "Eight months post-thyroidectomy: CT and abdominal MRI confirmed absence of metastatic lesions and stability of pelvic mass; serum calcitonin and CEA reported as stable (values not specified).",
        "Continued urological follow-up for vesicoureteral reflux and bladder involvement by plexiform neurofibroma."
      ]
    }
  ],
  "statistics": {
    "preop_ctdna_positive_count": null,
    "postop_ctdna_positive_count": null,
    "p_values": {
      "biomarker_correlations": null,
      "survival_associations": null
    },
    "correlation_coefficients": {
      "calcitonin_cea": null,
      "vaf_outcome": null
    }
  },
  "methods": {
    "sequencing_panel": "Germline RET analysis by Sanger sequencing of genomic DNA amplified by PCR; next-generation sequencing panel used for primary MTC tumor, neck lymph node metastasis, and plexiform neurofibroma to search for additional somatic mutations.",
    "biomarker_assays": "Serum calcitonin, calcium, and PTH measured with routine hospital assays (exact platforms not specified); bone-specific alkaline phosphatase, osteocalcin, metanephrines, and 25-hydroxyvitamin D also measured with standard methods.",
    "coverage_depth": {
      "tissue_mean": null,
      "ctdna_mean": null
    },
    "normal_ranges": {
      "calcitonin": "<18 ng/L",
      "calcium": "8.6-10.2 mg/dL",
      "PTH": "8-40 ng/L",
      "bone_specific_alkaline_phosphatase": "4.7-27.1 μg/L",
      "osteocalcin": "10.4-45.6 μg/L",
      "25_hydroxy_vitamin_D": ">30 μg/L"
    }
  }
}